Engineered immune cells take on Hard-to-Treat prostate cancer
NCT ID NCT05022849
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 27 times
Summary
This early-phase study tested a new treatment called JNJ-75229414, which uses a patient's own immune cells (CAR-T cells) to target a protein found on prostate cancer cells. The study involved 15 men with metastatic castration-resistant prostate cancer who had already tried other treatments. The main goals were to find the safest dose and to check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Cancer Center
Duarte, California, 91010, United States
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
-
Norton Cancer Institute
Louisville, Kentucky, 40207, United States
-
University Of Minnesota
Minneapolis, Minnesota, 55455, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
University of Utah Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
Conditions
Explore the condition pages connected to this study.